Department of Physical Medicine and Orthopaedic Surgery, Ghent University, Ghent, Belgium.
Department of Electronics and Information Systems, Ghent University, Ghent, Belgium.
Disabil Rehabil Assist Technol. 2021 Jan;16(1):27-39. doi: 10.1080/17483107.2019.1629114. Epub 2019 Jun 21.
Ankle foot orthosis (AFO) stiffness is a key characteristic that determines how much support or restraint an AFO can provide. Thus, the goal of the current study is twofold: (1) to quantify AFO prescriptions for a group of patients; (2) to evaluate what impact these AFO have on the push-off phase.
Six patients were included in the study. Three patients were prescribed an AFO for ankle support and three patients were prescribed an AFO for ankle and knee support. Two types of AFO - a traditional polypropylene AFO (AFOPP) and a novel carbon-selective laser sintered polyamide AFO (AFOPA), were produced for each patient. AFO ankle stiffness was measured in a dedicated test rig. Gait analysis was performed under shod and orthotic conditions.
Patient mass normalized AFOPP stiffness for ankle support ranged from 0.042 to 0.069 N·m·deg·kg, while for ankle and knee support it ranged from 0.081 to 0.127 N·m·deg·kg. On the group level, the ankle range of motion and mean ankle velocity in the push-off phase significantly decreased in both orthotic conditions, while peak ankle push-off power decreased non-significantly. Accordingly, on the group level, no significant improvements in walking speed were observed. However, after patient differentiation into good and bad responders it was found that in good responders peak ankle push-off power tended to be preserved and walking speed tended to increase.
Quantification of AFO stiffness may help to understand why certain orthotic interventions are successful (unsuccessful) and ultimately lead to better AFO prescriptions. Implications for rehabilitation AFO ankle stiffness is key characteristic that determines how much support or restraint an AFO can provide. In a typical clinical setting, AFO ankle stiffness is not quantified. AFO has to meet individual patient's biomechanical needs. More objective AFO prescription and more controlled AFO production methods are needed to increase AFO success rate.
踝足矫形器(AFO)的刚度是决定 AFO 能够提供多少支撑或限制的关键特性。因此,当前研究的目标有两个:(1)量化一组患者的 AFO 处方;(2)评估这些 AFO 对蹬离阶段的影响。
研究纳入了 6 名患者。其中 3 名患者因踝关节支撑而被处方 AFO,3 名患者因踝关节和膝关节支撑而被处方 AFO。为每位患者分别制作了两种 AFO——传统的聚丙烯 AFO(AFOPP)和新型的碳纤维选择性激光烧结聚酰胺 AFO(AFOPA)。在专用测试装置中测量 AFO 踝部刚度。在穿鞋和矫形条件下进行步态分析。
患者体重归一化的 AFOPP 踝支撑刚度范围为 0.042 至 0.069 N·m·deg·kg,而踝和膝支撑刚度范围为 0.081 至 0.127 N·m·deg·kg。在组水平上,在两种矫形条件下,踝关节的活动范围和蹬离阶段的平均踝关节速度都显著降低,而峰值踝关节蹬离功率则无显著降低。因此,在组水平上,没有观察到步行速度的显著提高。然而,在对患者进行良好和不良反应者的区分后发现,在良好反应者中,峰值踝关节蹬离功率有倾向于保留,步行速度有倾向于提高。
AFO 刚度的量化可能有助于理解为什么某些矫形干预措施是成功的(不成功的),并最终导致更好的 AFO 处方。对康复的影响 AFO 刚度是决定 AFO 能够提供多少支撑或限制的关键特性。在典型的临床环境中,AFO 踝部刚度没有被量化。AFO 必须满足个体患者的生物力学需求。需要更客观的 AFO 处方和更受控的 AFO 生产方法,以提高 AFO 的成功率。